Body fluids biomarkers associated with prognosis of acute ischemic stroke: progress and prospects

References

• Sacco RL, Kasner SE, Broderick JP et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7), 2064–2089 (2013).
   PubMed Web of Science ®Google Scholar
• Bathla G, Ajmera P, Mehta PM et al. Advances in acute ischemic stroke treatment: current status and future directions. AJNR Am. J. Neuroradiol. doi: 10.3174/ajnr.A7872 (2023).
   Web of Science ®Google Scholar
• Wang H, Zhang H, Zou Z. Changing profiles of cardiovascular disease and risk factors in China: a secondary analysis for the Global Burden of Disease Study 2019. Chin. Med. J. (Engl.). doi: 10.1097/cm9.0000000000002741 (2023).
   Web of Science ®Google Scholar
• Tu WJ, Zhao Z, Yin P et al. Estimated burden of stroke in China in 2020. JAMA Netw. Open 6(3), e231455 (2023).
   PubMed Web of Science ®Google Scholar
• Tu WJ, Wang LD. China stroke surveillance report 2021. Mil Med. Res. 10(1), 33 (2023).
   PubMed Web of Science ®Google Scholar
• Fan J, Li X, Yu X et al. Global burden, risk factors analysis, and prediction study of ischemic stroke, 1990–2030. Neurology doi: 10.1212/wnl.0000000000207387 (2023).
   Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 50(12), e344–e418 (2019).
   PubMed Web of Science ®Google Scholar
• Liang J, Liu W, Sun J, Gu X, Ma Q, Tong W. Analysis of the risk factors for the short-term prognosis of acute ischemic stroke. Int. J. Clin. Exp. Med. 8(11), 21915–21924 (2015).
   PubMed Web of Science ®Google Scholar
• Cavrak ME, Hass R, Stephens RJ, Adcock A, Petrone AB. Leukocyte biomarkers for the differential diagnosis of mild acute ischemic stroke, transient ischemic attack, and stroke mimic. Cureus 13(2), e13383 (2021).
   PubMed Web of Science ®Google Scholar
• Florijn BW, Leontien van der Bent M, Nguyen TMT et al. Non-coding RNAs versus protein biomarkers to diagnose and differentiate acute stroke: systematic review and meta-analysis. J. Stroke Cerebrovasc. Dis. 32(11), 107388 (2023).
   PubMed Web of Science ®Google Scholar
• Voznyuk IA, Pivovarova LP, Gogoleva EA et al. [Biomarkers of brain damage and inflammation in patients with acute cerebral ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 122(8. Vyp. 2), 54–60 (2022).
   PubMedGoogle Scholar
• Guimãraes de Almeida Barros A, Roquim E Silva L, Pessoa A et al. Use of biomarkers for predicting a malignant course in acute ischemic stroke: an observational case-control study. Sci. Rep. 13(1), 16097 (2023).
   PubMed Web of Science ®Google Scholar
• Hou D, Wang C, Luo Y et al. Systemic immune-inflammation index (SII) but not platelet-albumin-bilirubin (PALBI) grade is associated with severity of acute ischemic stroke (AIS). Int. J. Neurosci. 131(12), 1203–1208 (2021).
   PubMed Web of Science ®Google Scholar
• Lasek-Bal A, Jedrzejowska-Szypulka H, Student S et al. The importance of selected markers of inflammation and blood–brain barrier damage for short-term ischemic stroke prognosis. J. Physiol. Pharmacol. 70(2), 209–217 (2019).
   Web of Science ®Google Scholar
• Li J, Pan Y, Xu J et al. Residual inflammatory risk predicts poor prognosis in acute ischemic stroke or transient ischemic attack patients. Stroke 52(9), 2827–2836 (2021).
   PubMed Web of Science ®Google Scholar
• Qiu YM, Zhang CL, Chen AQ et al. Immune cells in the BBB disruption after acute ischemic stroke: targets for immune therapy? Front. Immunol. 12, 678744 (2021).
   PubMed Web of Science ®Google Scholar
• Paudel SS, Thapa B, Luitel R. Neutrophil lymphocyte ratio as a prognostic marker in acute ischemic stroke: a systematic review and meta-analysis. J. Nepal Health Res. Counc. 18(4), 573–579 (2021).
   PubMedGoogle Scholar
• Chen C, Gu L, Chen L et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential predictors of prognosis in acute ischemic stroke. Front. Neurol. 11, 525621 (2020).
   PubMed Web of Science ®Google Scholar
• Sharma D, Spring KJ, Bhaskar SMM. Role of neutrophil-lymphocyte ratio in the prognosis of acute ischaemic stroke after reperfusion therapy: a systematic review and meta-analysis. J. Cent. Nerv. Syst. Dis. 14, 11795735221092518 (2022).
   Web of Science ®Google Scholar
• Aly M, Abdalla RN, Batra A et al. Follow-up neutrophil-lymphocyte ratio after stroke thrombectomy is an independent biomarker of clinical outcome. J. Neurointerv. Surg. 13(7), 609–613 (2021).
   PubMed Web of Science ®Google Scholar
• Sadeghi F, Sarkady F, Zsóri KS et al. High neutrophil-lymphocyte ratio and low lymphocyte-monocyte ratio combination after thrombolysis is a potential predictor of poor functional outcome of acute ischemic stroke. J. Pers Med. 12(8), 1221 (2022).
   PubMed Web of Science ®Google Scholar
• Zhu F, Ji Y, Song JH, Zhang YF. Correlations between NLR, NHR, and clinicopathological characteristics, and prognosis of acute ischemic stroke. Medicine (Baltimore) 102(24), e33957 (2023).
   PubMed Web of Science ®Google Scholar
• Li LH, Chen CT, Chang YC, Chen YJ, Lee IH, How CK. Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune inflammation index in acute ischemic stroke: A STROBE-compliant retrospective study. Medicine (Baltimore) 100(25), e26354 (2021).
   PubMed Web of Science ®Google Scholar
• Gong P, Liu Y, Gong Y et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation. 18(1), 51 (2021).
   PubMed Web of Science ®Google Scholar
• Lattanzi S, Norata D, Broggi S et al. Neutrophil-to-lymphocyte ratio predicts early neurological deterioration after endovascular treatment in patients with ischemic stroke. Life (Basel). 12(9), 1415 (2022).
   PubMed Web of Science ®Google Scholar
• Huang G, Chen H, Wang Q et al. High platelet-to-lymphocyte ratio are associated with post-stroke depression. J. Affect. Disord. 246, 105–111 (2019).
   PubMed Web of Science ®Google Scholar
• Pan H, Fu M, Ge W, Zhou C. The effects of changes in platelet-to-neutrophil ratios 24 hours after intravenous thrombolysis on prognosis in acute ischemic stroke patients. Clin. Neurol. Neurosurg. 190, 105739 (2020).
   PubMed Web of Science ®Google Scholar
• Pincakova K, Krastev G, Haring J, Mako M, Mikulaskova V, Bosak V. Low lymphocyte-to-monocyte ratio as a possible predictor of an unfavourable clinical outcome in patients with acute ischemic stroke after mechanical Thrombectomy. Stroke Res Treat. 2022, 9243080 (2022).
   PubMed Web of Science ®Google Scholar
• Chong L, Han L, Liu R, Ma G, Ren H. Association of lymphocyte-to-monocyte ratio with poststroke depression in patients with acute ischemic stroke. Med. Sci. Monit. 27, e930076 (2021).
   PubMed Web of Science ®Google Scholar
• Weng Y, Gao Y, Zhao M et al. The white blood cell count to mean platelet volume ratio for ischemic stroke patients after intravenous thrombolysis. Front. Immunol. 13, 995911 (2022).
   PubMed Web of Science ®Google Scholar
• Huang L. Increased systemic immune-inflammation index predicts disease severity and functional outcome in acute ischemic stroke patients. Neurologist 28(1), 32–38 (2023).
   PubMed Web of Science ®Google Scholar
• Yang Y, Cui T, Bai X et al. Association between systemic immune-inflammation index and symptomatic intracranial hemorrhage in acute ischemic stroke patients undergoing endovascular treatment. Curr. Neurovasc. Res. 19(1), 83–91 (2022).
   PubMed Web of Science ®Google Scholar
• Weng Y, Zeng T, Huang H et al. Systemic immune-inflammation index predicts 3-month functional outcome in acute ischemic stroke patients treated with intravenous thrombolysis. Clin. Interv. Aging 16, 877–886 (2021).
   PubMed Web of Science ®Google Scholar
• Wu S, Shi X, Zhou Q, Duan X, Zhang X, Guo H. The association between systemic immune-inflammation index and all-cause mortality in acute ischemic stroke patients: analysis from the MIMIC-IV database. Emerg. Med. Int. 2022, 4156489 (2022).
   PubMed Web of Science ®Google Scholar
• Lattanzi S, Norata D, Divani AA et al. Systemic inflammatory response index and futile recanalization in patients with ischemic stroke undergoing endovascular treatment. Brain Sci. 11(9), 1164 (2021).
   PubMed Web of Science ®Google Scholar
• Chen YF, Qi S, Yu ZJ et al. Systemic inflammation response index predicts clinical outcomes in patients with acute ischemic stroke (AIS) after the treatment of intravenous thrombolysis. Neurologist doi: 10.1097/NRL.0000000000000492 (2023).
   Web of Science ®Google Scholar
• Chu M, Luo Y, Wang D et al. Systemic inflammation response index predicts 3-month outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis. Front. Neurol. 14, 1095668 (2023).
   PubMed Web of Science ®Google Scholar
• Dang H, Mao W, Wang S et al. Systemic inflammation response index as a prognostic predictor in patients with acute ischemic stroke: a propensity score matching analysis. Front. Neurol. 13, 1049241 (2022).
   PubMed Web of Science ®Google Scholar
• Qu X, Shi J, Cao Y, Zhang M, Xu J. Prognostic value of white blood cell counts and c-reactive protein in acute ischemic stroke patients after intravenous thrombolysis. Curr. Neurovasc. Res. 15(1), 10–17 (2018).
   PubMed Web of Science ®Google Scholar
• Malhotra K, Goyal N, Chang JJ et al. Differential leukocyte counts on admission predict outcomes in patients with acute ischaemic stroke treated with intravenous thrombolysis. Eur. J. Neurol. 25(12), 1417–1424 (2018).
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang Z, Chen L et al. Correlation of changes in leukocytes levels 24 hours after intravenous thrombolysis with prognosis in patients with acute ischemic stroke. J. Stroke Cerebrovasc. Dis. 27(10), 2857–2862 (2018).
   PubMed Web of Science ®Google Scholar
• Yan L, Wang S, Xu L, Zhang Z, Liao P. Procalcitonin as a prognostic marker of patients with acute ischemic stroke. J. Clin. Lab. Anal. 34(7), e23301 (2020).
   PubMed Web of Science ®Google Scholar
• Li X, Lin S, Chen X et al. The Prognostic Value of Serum Cytokines in Patients with Acute Ischemic Stroke. Aging Dis. 10(3), 544–556 (2019).
   PubMed Web of Science ®Google Scholar
• Deng QW, Huang S, Li S et al. Inflammatory Factors as Potential Markers of Early Neurological Deterioration in Acute Ischemic Stroke Patients Receiving Endovascular Therapy - The AISRNA Study. J. Inflamm. Res. 14, 4399–4407 (2021).
   PubMed Web of Science ®Google Scholar
• Chi CH, Huang YY, Ye SZ et al. Interleukin-10 level is associated with post-stroke depression in acute ischaemic stroke patients. J. Affect. Disord. 293, 254–260 (2021).
   PubMed Web of Science ®Google Scholar
• Chen Z, Hu Q, Huo Y, Zhang R, Fu Q, Qin X. Serum Interleukin-33 is a Novel Predictive Biomarker of Hemorrhage Transformation and Outcome in Acute Ischemic Stroke. J. Stroke Cerebrovasc. Dis. 30(2), 105506 (2021).
   PubMed Web of Science ®Google Scholar
• Jin P, Li X, Chen J et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke. J. Clin. Neurosci. 63, 110–115 (2019).
   PubMed Web of Science ®Google Scholar
• Boisseau W, Desilles JP, Fahed R et al. Neutrophil count predicts poor outcome despite recanalization after endovascular therapy. Neurology 93(5), e467–e475 (2019).
   PubMed Web of Science ®Google Scholar
• Ren H, Han L, Liu H, Wang L, Liu X, Gao Y. Decreased Lymphocyte-to-Monocyte Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Treated with Thrombolysis. Med. Sci. Monit. 23, 5826–5833 (2017).
   PubMed Web of Science ®Google Scholar
• Zhao HM, Qin WQ, Wang PJ, Wen ZM. Eosinopenia is a predictive factor for the severity of acute ischemic stroke. Neural Regen. Res. 14(10), 1772–1779 (2019).
   PubMed Web of Science ®Google Scholar
• Yang D, Huang H, Weng Y et al. Dynamic Decrease in Eosinophil After Intravenous Thrombolysis Predicts Poor Prognosis of Acute Ischemic Stroke: A Longitudinal Study. Front. Immunol. 12, 709289 (2021).
   PubMed Web of Science ®Google Scholar
• Jucevičiūtė N, Mikužis P, Balnytė R. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke. BMC Neurol. 19(1), 127 (2019).
   PubMedGoogle Scholar
• Gao B, Pan W, Hu X et al. Neutrophil-Related Ratios Predict the 90-Day Outcome in Acute Ischemic Stroke Patients After Intravenous Thrombolysis. Front. Physiol. 12, 670323 (2021).
   PubMed Web of Science ®Google Scholar
• Güneş M. Is neutrophil/eosinophil ratio at admission a prognostic marker for in-hospital mortality of acute ischemic stroke? J. Stroke Cerebrovasc. Dis. 29(8), 104999 (2020).
   PubMed Web of Science ®Google Scholar
• Bian J, Guo S, Huang T et al. CRP as a potential predictor of outcome in acute ischemic stroke. Biomed. Rep. 18(2), 17 (2023).
   PubMed Web of Science ®Google Scholar
• Deng WJ, Shen RL, Li M, Teng JF. Relationship between procalcitonin serum levels and functional outcome in stroke patients. Cell. Mol. Neurobiol. 35(3), 355–361 (2015).
   PubMed Web of Science ®Google Scholar
• Qian L, Yuanshao L, Wensi H et al. Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke. Aging Dis. 7(5), 614–622 (2016).
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang R, Wu Y, Fu Q, Qin X. Serum Interleukin-33 is a Predictor of Depression in Patients with Acute Ischemic Stroke. Curr. Neurovasc. Res. 17(5), 719–724 (2020).
   PubMed Web of Science ®Google Scholar
• Sun W, Wang S, Nan S. The Prognostic Determinant of Interleukin-10 in Patients with Acute Ischemic Stroke: An Analysis from the Perspective of Disease Management. Dis. Markers 2021, 6423244 (2021).
   PubMed Web of Science ®Google Scholar
• Vallés J, Lago A, Santos MT et al. Neutrophil extracellular traps are increased in patients with acute ischemic stroke: prognostic significance. Thromb. Haemost. 117(10), 1919–1929 (2017).
   PubMed Web of Science ®Google Scholar
• Rainer TH, Wong LK, Lam W et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin. Chem. 49(4), 562–569 (2003).
   PubMed Web of Science ®Google Scholar
• Wang SW, Liu Z, Shi ZS. Non-Coding RNA in Acute Ischemic Stroke: Mechanisms, Biomarkers and Therapeutic Targets. Cell Transplant. 27(12), 1763–1777 (2018).
   PubMed Web of Science ®Google Scholar
• He XW, Shi YH, Liu YS et al. Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis. Atherosclerosis 289, 36–43 (2019).
   PubMed Web of Science ®Google Scholar
• Wang G, Zhou Y, Zhong T, Song A, Xue Q. The role of blood lnc-ZFAS1 in acute ischemic stroke: correlation with neurological impairment, inflammation, and survival profiles. J. Clin. Lab. Anal. 36(2), e24219 (2022).
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang F, Fu F, Liu J, Sun W, Chen Y. Diagnostic and prognostic value of serum miR-9-5p and miR-128-3p levels in early-stage acute ischemic stroke. Clinics (Sao Paulo). 76, e2958 (2021).
   PubMed Web of Science ®Google Scholar
• Song X, Liu J, Wang Y, Zheng L, Liu M. Serum microRNA miR-491-5p/miR-206 Is Correlated with Poor Outcomes/Spontaneous Hemorrhagic Transformation after Ischemic Stroke: A Case Control Study. Brain Sci. 12(8), (2022).
   Web of Science ®Google Scholar
• Guo C, Zhong C, Li Q, Gao Y, Li W, Ou Y. [Expressions and neural function prognostic evaluation of serum microRNA-24 and microRNA-29b in elderly patients with acute ischemic stroke]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 32(1), 78–82 (2020).
   PubMedGoogle Scholar
• Guo C, Yao Y, Li Q, Gao Y, Cao H. Expression and Clinical Value of miR-185 and miR-424 in Patients with Acute Ischemic Stroke. Int. J. Gen. Med. 15, 71–78 (2022).
   PubMed Web of Science ®Google Scholar
• Li P, Duan S, Fu A. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke. J. Clin. Lab. Anal. 34(2), e23056 (2020).
   PubMed Web of Science ®Google Scholar
• Ren B, Song Z, Chen L, Niu X, Feng Q. Long non-coding RNA UCA1 correlates with elevated disease severity, Th17 cell proportion, inflammatory cytokines, and worse prognosis in acute ischemic stroke patients. J. Clin. Lab. Anal. 35(3), e23697 (2021).
   PubMed Web of Science ®Google Scholar
• Fang P, Wu Y, Zhang Z et al. The clinical value of long noncoding RNA GAS5 in acute ischemic stroke: correlation with disease risk, inflammation, severity, and risk of recurrence. J. Clin. Lab. Anal. 36(1), e24171 (2022).
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang X, Su C, Huang S. Long noncoding RNA HULC in acute ischemic stroke: association with disease risk, severity, and recurrence-free survival and relation with IL-6, ICAM1, miR-9, and miR-195. J. Clin. Lab. Anal. 34(11), e23500 (2020).
   PubMed Web of Science ®Google Scholar
• Liu D, Li L, Xu J et al. Upregulated lncRNA NORAD can diagnose acute cerebral ischemic stroke patients and predict poor prognosis. Folia Neuropathol. 61(1), 105–110 (2023).
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang X, Lan L, Xu G, Li Y, Huang S. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke. J. Clin. Lab. Anal. 35(9), e23903 (2021).
   PubMed Web of Science ®Google Scholar
• Vajpeyee A, Wijatmiko T, Vajpeyee M, Taywade O, Pandey S, Chauhan PS. Clinical usefulness of cell-free DNA as a prognostic marker in acute ischemic stroke. Neurologist 25(1), 11–13 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang C, Qian S, Zhang R et al. Endostatin as a novel prognostic biomarker in acute ischemic stroke. Atherosclerosis 293, 42–48 (2020).
   PubMed Web of Science ®Google Scholar
• Gupta HV, Finlay CW, Jacob S, Raina SK, Lee RW, Hinduja A. Can admission BNP level predict outcome after intravenous thrombolysis in acute ischemic stroke? Neurologist. 24(1), 6–9 (2019).
   PubMed Web of Science ®Google Scholar
• Naveen V, Vengamma B, Mohan A, Vanajakshamma V. N-terminal pro-brain natriuretic peptide levels and short term prognosis in acute ischemic stroke. Ann. Indian Acad. Neurol. 18(4), 435–440 (2015).
   PubMed Web of Science ®Google Scholar
• Sultana J, Sharma DJ. Evaluation of serum ferritin as a prognostic marker in acute ischemic stroke patients - a prospective cohort study. J. Assoc. Physicians India 70(4), 11–12 (2022).
   PubMedGoogle Scholar
• Garg R, Aravind S, Kaur S, Singh Chawla SP, Aggarwal S, Goyal G. Role of serum ferritin as a prognostic marker in acute ischemic stroke: a preliminary observation. Ann. Afr. Med. 19(2), 95–102 (2020).
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhu Z, Guo D et al. Prognostic value of plasma fibroblast growth factor 21 among patients with acute ischemic stroke. Eur. J. Neurol. 28(3), 844–851 (2021).
   PubMed Web of Science ®Google Scholar
• Tan C, Wang H, Gao X et al. Dynamic changes and prognostic value of gut microbiota-dependent trimethylamine-n-oxide in acute ischemic stroke. Front. Neurol. 11, 29 (2020).
   PubMed Web of Science ®Google Scholar
• He L, Wang J, Dong W. The clinical prognostic significance of hs-cTnT elevation in patients with acute ischemic stroke. BMC Neurol. 18(1), 118 (2018).
   PubMedGoogle Scholar
• Zhang X, Zhang W, Wu X et al. Prognostic significance of plasma CLEC-2 (C-type lectin-like receptor 2) in patients with acute ischemic stroke. Stroke doi: 10.1161/strokeaha.118.022563 Strokeaha118022563 (2018).
   PubMed Web of Science ®Google Scholar
• Bu X, Peng H, Zhong C et al. Antiphosphatidylserine antibodies and clinical outcomes in patients with acute ischemic stroke. Stroke 47(11), 2742–2748 (2016).
   PubMed Web of Science ®Google Scholar
• Hayes CA, Valcarcel-Ares MN, Ashpole NM. Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke. J. Cereb. Blood Flow Metab. 41(10), 2475–2491 (2021).
   PubMed Web of Science ®Google Scholar
• Gui YK, Li Q, Liu L et al. Plasma levels of ceramides relate to ischemic stroke risk and clinical severity. Brain Res. Bull. 158, 122–127 (2020).
   PubMed Web of Science ®Google Scholar
• Donn SM, Faix RG, Roloff DW, Goldman EB. Medico-legal consultation: an expanded role of the tertiary neonatologist. J. Perinatol. 7(3), 238–241 (1987).
   PubMedGoogle Scholar
• Lee TH, Cheng CN, Lee CW, Kuo CH, Tang SC, Jeng JS. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment. J. Formos. Med. Assoc. 122(1), 19–28 (2023).
   PubMed Web of Science ®Google Scholar
• Lundbeck F, Bruun E, Finnerup B, Christophersen IS. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin: initial treatment results and the long-term course. J. Urol. 139(6), 1212–1213 (1988).
   PubMed Web of Science ®Google Scholar
• Yang X, Lu T, Qu Z, Zhang Y, Liu P, Ma Y. Plasma D-dimer level is associated with clinical outcomes in patients with atrial fibrillation related acute ischemic stroke after pneumonia. BMC Neurol. 21(1), 137 (2021).
   PubMed Web of Science ®Google Scholar
• Wu J, Wu D, Liang Y, Zhang Z, Zhuang L, Wang Z. Plasma neurofilament light chain: a biomarker predicting severity in patients with acute ischemic stroke. Medicine (Baltimore). 101(26), e29692 (2022).
   PubMed Web of Science ®Google Scholar
• Gao L, Xie J, Zhang H et al. Neuron-specific enolase in hypertension patients with acute ischemic stroke and its value forecasting long-term functional outcomes. BMC Geriatr. 23(1), 294 (2023).
   PubMed Web of Science ®Google Scholar
• Eyileten C, Kaplon-Cieslicka A, Mirowska-Guzel D, Malek L, Postula M. Antidiabetic effect of brain-derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus. J. Diabetes Res. 2017, 2823671 (2017).
   PubMed Web of Science ®Google Scholar
• Eyileten C, Mirowska-Guzel D, Milanowski L et al. Serum brain-derived neurotrophic factor is related to platelet reactivity and metformin treatment in adult patients with type 2 diabetes mellitus. Can. J. Diabetes. 43(1), 19–26 (2019).
   PubMed Web of Science ®Google Scholar
• Lasek-Bal A, Jędrzejowska-Szypułka H, Różycka J et al. Low concentration of BDNF in the acute phase of ischemic stroke as a factor in poor prognosis in terms of functional status of patients. Med. Sci. Monit. 21, 3900–3905 (2015).
   PubMed Web of Science ®Google Scholar
• Mirowska-Guzel D, Gromadzka G, Mendel T et al. Impact of BDNF -196 G >A and BDNF -270 C >T polymorphisms on stroke rehabilitation outcome: sex and age differences. Top. Stroke Rehabil. 21(Suppl. 1), S33–S41 (2014).
   PubMedGoogle Scholar
• Mirowska-Guzel D, Gromadzka G, Seniow J et al. Association between BDNF-196 G >A and BDNF-270 C >T polymorphisms, BDNF concentration, and rTMS-supported long-term rehabilitation outcome after ischemic stroke. NeuroRehabilitation. 32(3), 573–582 (2013).
   PubMed Web of Science ®Google Scholar
• Wang C, Tian C, Cai D et al. BDNF-overexpressing MSCs delivered by hydrogel in acute ischemic stroke treatment. Ann. Transl. Med. 10(24), 1393 (2022).
   PubMed Web of Science ®Google Scholar
• Li J, Qiu Y, Zhang C et al. The role of protein glycosylation in the occurrence and outcome of acute ischemic stroke. Pharmacol. Res. 191, 106726 (2023).
   PubMed Web of Science ®Google Scholar
• Kanamaru T, Suda S, Muraga K et al. Albuminuria predicts early neurological deterioration in patients with acute ischemic stroke. J. Neurol. Sci. 372, 417–420 (2017).
   PubMed Web of Science ®Google Scholar
• Huang YC, Wu YL, Lee MH et al. Association of renal biomarkers with 3-month and 1-year outcomes among critically ill acute stroke patients. PLOS ONE 8(9), e72971 (2013).
   PubMed Web of Science ®Google Scholar
• Strain WD, Elyas S, Wedge N et al. Evaluation of microalbuminuria as a prognostic indicator after a TIA or minor stroke in an outpatient setting: the prognostic role of microalbuminuria in TIA evolution (ProMOTE) study. BMJ Open. 11(9), e043253 (2021).
   PubMed Web of Science ®Google Scholar
• Wang A, Tian X, Zuo Y et al. Urine ketone bodies and adverse outcomes in patients with acute ischemic stroke or TIA. Atheroscler. Plus 48, 20–26 (2022).
   PubMedGoogle Scholar
• You S, Xu J, Ou Z et al. Prognostic significance of urinary protein and urinary ketone bodies in acute ischemic stroke. Nutr. Metab. Cardiovasc. Dis. 31(11), 3152–3160 (2021).
   PubMed Web of Science ®Google Scholar
• Ishihara M, Nakanishi N, Tsutsumi R et al. Elevated urinary titin and its associated clinical outcomes after acute stroke. J. Stroke Cerebrovasc. Dis. 30(3), 105561 (2021).
   PubMed Web of Science ®Google Scholar
• Arai R, Suzuki S, Kano H et al. Role of dipstick proteinuria for predicting cardiovascular events: a Japanese cardiovascular hospital database analysis. Heart Vessels 35(9), 1256–1269 (2020).
   PubMed Web of Science ®Google Scholar
• Sun W, Huang S, Yang X, Luo Y, Liu L, Wu D. The oral microbiome of patients with ischemic stroke predicts their severity and prognosis. Front. Immunol. 14, 1171898 (2023).
   PubMed Web of Science ®Google Scholar
• De Vos A, Bjerke M, Brouns R et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC Neurol. 17(1), 170 (2017).
   PubMedGoogle Scholar
• Brouns R, De Vil B, Cras P, De Surgeloose D, Marien P, De Deyn PP. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin. Chem. 56(3), 451–458 (2010).
   PubMed Web of Science ®Google Scholar
• Mertens JC, Leenaerts D, Brouns R et al. Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction. J Thromb Haemost. 16(2), 342–348 (2018).
   PubMed Web of Science ®Google Scholar
• Buoite Stella A, Gaio M, Furlanis G et al. Prevalence of hypohydration and its association with stroke severity and independence outcomes in acute ischemic stroke patients. J. Clin. Neurosci. 72, 281–286 (2020).
   PubMed Web of Science ®Google Scholar
• Buoite Stella A, Ajčević M, Furlanis G et al. A physiological perspective of the associations between hydration status and CTP neuroimaging parameters in hyper-acute ischaemic stroke patients. Clin. Physiol. Funct. Imaging. 41(3), 235–244 (2021).
   PubMed Web of Science ®Google Scholar
• Ling X, Zhang G, Xia Y et al. Exosomes from human urine-derived stem cells enhanced neurogenesis via miR-26a/HDAC6 axis after ischaemic stroke. J. Cell. Mol. Med. 24(1), 640–654 (2020).
   PubMed Web of Science ®Google Scholar
• Chen YL, Bai L, Dilimulati D et al. Periodontitis salivary microbiota aggravates ischemic stroke through IL-17A. Front. Neurosci. 16, 876582 (2022).
   PubMed Web of Science ®Google Scholar
• Palm F, Lahdentausta L, Sorsa T et al. Biomarkers of periodontitis and inflammation in ischemic stroke: a case-control study. Innate Immun. 20(5), 511–518 (2014).
   PubMed Web of Science ®Google Scholar
• Dusanovic Pjevic M, Jekic B, Beslac Bumbasirevic L et al. TT genotype of the MMP-9-1562C/T polymorphism may be a risk factor for thrombolytic therapy-induced hemorrhagic complications after acute ischemic stroke. Pharmacotherapy 41(7), 562–571 (2021).
   PubMed Web of Science ®Google Scholar
• Maciejczyk M, Mil KM, Gerreth P, Hojan K, Zalewska A, Gerreth K. Salivary cytokine profile in patients with ischemic stroke. Sci. Rep. 11(1), 17185 (2021).
   PubMed Web of Science ®Google Scholar
• Maciejczyk M, Nesterowicz M, Zalewska A et al. Salivary xanthine oxidase as a potential biomarker in stroke diagnostics. Front. Immunol. 13, 897413 (2022).
   PubMed Web of Science ®Google Scholar
• Smith AK, Kilaru V, Klengel T et al. DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168B(1), 36–44 (2015).
   PubMedGoogle Scholar
• Thomas M, Knoblich N, Wallisch A et al. Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder. Clin Epigenetics. 10(1), 109 (2018).
   PubMed Web of Science ®Google Scholar
• Martin J, Kagerbauer SM, Gempt J, Podtschaske A, Hapfelmeier A, Schneider G. Oxytocin levels in saliva correlate better than plasma levels with concentrations in the cerebrospinal fluid of patients in neurocritical care. J. Neuroendocrinol. doi: 10.1111/jne.12596 e12596 (2018).
   PubMed Web of Science ®Google Scholar
• Xiang Y, Xin J, Le W, Yang Y. Neurogranin: a potential biomarker of neurological and mental diseases. Front. Aging Neurosci. 12, 584743 (2020).
   PubMed Web of Science ®Google Scholar
• Santacruz CA, Vincent JL, Bader A et al. Association of cerebrospinal fluid protein biomarkers with outcomes in patients with traumatic and non-traumatic acute brain injury: systematic review of the literature. Crit. Care. 25(1), 278 (2021).
   PubMed Web of Science ®Google Scholar
• Kulesh A, Drobakha V, Kuklina E, Nekrasova I, Shestakov V. Cytokine response, tract-specific fractional anisotropy, and brain morphometry in post-stroke cognitive impairment. J. Stroke Cerebrovasc. Dis. 27(7), 1752–1759 (2018).
   PubMed Web of Science ®Google Scholar